Minerva Surgical
Update in progressUTRS (OTC Markets OTCPK)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Minerva Surgical, Inc. develops devices to treat abnormal uterine bleeding in the United States. Its products include the Minerva Endometrial Ablation System, which uses three ablation methods; the Symphion System for fluid management and intrauterine pressure monitoring; Genesys HTA for endometrial ablation in a broad range of uterine cavities; Resectr for polyp resection; and the HERizon hysteroscope with accessories for evaluation and care. Founded 2008, based in Santa Clara, California.
Company score
- Sentiment
- -0.01
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.33
- Governance
- -0.01
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.04
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketOTC Markets OTCPK (PNK)
- LocationUnited States
- Founded2008
- Employees174
- Websiteminervasurgical.com
Identifiers
- ISINUS60343F1066
- FIGIBBG00200BS28
- CUSIP60343F106
- CIK0001452965